Subject of bioequivalence test will be extended to powder and granule
Bioequivalence tests, which have only been conducted on tablets, capsules and suppositories, will be extended to powder and granule products from November 2018.
The Ministry of Food and Drug Safety(MFDS) held the ‘Civil Complaint Briefing on Drug Approval and Evaluation’ with people concerned to...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.